Cases 1 - 7 of 7
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALITIES LTD. et al
as 1:2024cv00150
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALITIES LTD. et al
as 1:2023cv06667
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Counter Claimant:
LUPIN INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED
as 1:2023cv02843
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 1:2023cv00926
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 2:2023cv00926
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Radius Health, Inc. et al v. Orbicular Pharmaceutical Technologies Private Limited
as 1:2022cv11546
Plaintiff:
Radius Health, Inc. and Ipsen Pharma S.A.S.
Defendant:
Orbicular Pharmaceutical Technologies Private Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED et al v. ELI LILLY AND COMPANY
as 1:2022cv01130
Plaintiff:
Orbicular Pharmaceutical Technologies Private Limited and CIPLA USA, INC.
Defendant:
ELI LILLY AND COMPANY
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
